Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: A mechanism for lineage determination in myogenesis

Genes and Development

Volumn 11, Issue 4, 1997, Pages 436-450

  Gerber, Anthony N ^a,b   Klesert, Todd R ^a,b   Bergstrom, Donald A ^a,b   Tapscott, Stephen J ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

chromatin; Myf5; MyoD; myogenesis; myogenin; transcription

Indexed keywords

BUTYRIC ACID; MYOGENIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMATIN; ENHANCER REGION; GENE ACTIVATION; GENE DELETION; GENE MUTATION; GENE REPRESSION; GENETIC TRANSCRIPTION; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; SKELETAL MUSCLE; TRANSCRIPTION INITIATION;

EID: 0031034468     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.4.436     Document Type: Article

References (75)

1. Adolph, E.A., A. Subramaniam, P. Cserjesi, E.N. Olson, and J. Robbins. 1993. Role of myocyte-specific enhancer-binding factor (MEF-2) in transcriptional regulation of the alpha-cardiac myosin heavy chain gene. J. Biol. Chem. 268: 5349-5352.
2. Alevizopoulos, A., Y. Dusserre, M. Tsai-Pflugfelder, T. von der Weid, W. Wahli, and N. Mermod. 1995. A proline-rich TGF-β-responsive transcriptional activator interacts with histone H3. Genes & Dev. 9: 3051-3066.
3. Archer, T.K., P. Lefebvre, R.G. Wolford, and G.L. Hager. 1992. Transcription factor loading on the MMTV promoter: A bimodal mechanism for promoter activation. Science 255: 1573-1576.
4. Asakura, A., A. Fujisawa-Sehara, T. Komiya, and Y. Nabeshima. 1993. MyoD and myogenin act on the chicken myosin light-chain 1 gene as distinct transcriptional factors. Mol. Cell. Biol. 13: 7153-7162.
5. Barton, M.C., N. Madani, and B.M. Emerson. 1993. The erythroid protein cGATA-1 functions with a stage-specific factor to activate transcription of chromatin-assembled β-globin genes. Genes & Dev. 7: 1796-1809.
6. Biben, C., B.J. Kirschbaum, I. Garner, and M. Buckingham. 1994. Novel muscle-specific enhancer sequences upstream of the cardiac actin gene. Mol Cell. Biol. 14: 3504-3513.
7. Black, B.L., J.F. Martin, and E.N. Olson. 1995. The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors. J. Biol. Chem. 270: 2889-2892.
8. Blackwell, T.K. and H. Weintraub. 1990. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250: 1104-1110.
9. Boyes, J. and G. Felsenfeld. 1996. Tissue-specific factors additively increases the probability of the all-or-none formation of a hypersensitive site. EMBO J. 15: 2496-2507.
10. Braun, T. and H.H. Arnold. 1996. Myf-5 and myoD genes are activated in distinct mesenchymal stem cells and determine different skeletal muscle cell lineages. EMBO J. 15: 310-318.
11. Braun, T., E. Bober, M.A. Rudnicki, R. Jaenisch, and H.H. Arnold. 1994. MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice. Development 120: 3083-3092.
12. Buckingham, M. 1992. Making muscle in mammals. Trends Genet. 8: 144-148.
13. Catala, F., R. Wanner, P. Barton, A. Cohen, W. Wright, and M. Buckingham. 1995. A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promoter of the mouse myosin light-chain IA gene. Mol. Cell. Biol. 15: 4585-4595.
14. Chakravarti, D., V.J. LaMorte, M.C. Nelson, T. Nakajima, I.G. Schulman, H. Juguilon, M. Montiminy, and R.M. Evans. 1996. Role of CBP/P300 in nuclear receptor signalling. Nature 383: 99-103.
15. Chen, A.C., N. Kraut, M. Groudine, and H. Wemtraub. 1996. I-mf, a novel myogenic repressor, interacts with members of the MyoD family. Cell 86: 731-741.
16. Cheng, T.C., M.C. Wallace, J.P. Merlie, and E.N. Olson. 1993. Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science 261: 215-218.
17. Clark, D.J. and G. Felsenfeld. 1992. A nucleosome core is transferred out of the path of a transcribing polymerase. Cell 71: 11-22.
18. Cote, I., J. Quinn, J.L. Workman, and C.L. Peterson. 1994. Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science 265: 53-60.
19. Eckner, R., T. Yao, E. Oldread, and D.M. Livingston. 1996. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes & Dev. 10: 2478-2490.
20. Edmondson, D.G. and E.N. Olson. 1993. Helix-loop-helix proteins as regulators of muscle-specific transcription. J. Biol. Chem. 268: 755-758.
21. Edmondson, D.G., T.C. Cheng, P. Cseriesi, T. Chakraborty, and E.N. Olson. 1992. Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol. Cell. Biol. 12: 3665-3677.
22. Fascher, K.D., J. Schmitz, and W. Horz. 1993. Structural and functional requirements for the chromatin transition at the PHO5 promoter in Saccharomyces cerevisiae upon PHO5 activation. J. Mol. Biol. 231: 658 -667.
23. Felsenfeld, G., J. Boyes, J. Chung, D. Clark, and V. Studitsky. 1996. Chromatin structure and gene expression. Proc. Natl. Acad. Sci. 93: 9384-9388.
24. Gerber, A.N. and S.J. Tapscott. 1996. Tumor cell complementation groups based on myogenic potential: Evidence for inactivation of loci required for basic helix-loop-helix protein activity. Mol. Cell. Biol. 16: 3901-3908.
25. Granok, H., B.A. Leibovitch, C.D. Shaffer, and S.C.R. Elgin. 1995. Ga-ga over GAGA factor. Curr. Biol. 5: 238-241.
26. Groudine, M. and H. Weintraub. 1982. Propagation ot globin DNase I-hypersensitive sites in absence of factors required for induction: A possible mechanism for determination. Cell 30: 131-139.
27. Hannon, K., C.K. Smith, K.R. Bales, and R.F. Santerre. 1992. Temporal and quantitative analysis of myogenic regulatory and growth factor gene expression in the developing mouse embryo. Dev. Biol. 151: 137-144.
28. Hanstein, B., R. Eckner, J. DiRenzo, S. Halachmi, H. Liu, B. Searey, R. Kurokawa, and M. Brown. 1996. p300 is a component of an estrogen receptor coactivator complex, Proc. Natl. Acad. Sci. 93: 11540-11545.
29. Hasty, P., A. Bradley, J.H. Morris, D.G. Edmondson, J.M. Venuti, E.N. Olson, and W.H. Klein. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene [see comments]. Nature 364: 501-506.
30. Hollenberg, S.M., P.F. Cheng, and H. Weintraub. 1993. Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination. Proc. Natl. Acad. Sci. 90: 8028-8032.
31. Jaynes, J.B., J.E. Johnson, J.N. Buskin, C.L. Gartside, and S.D. Hauschka. 1988. The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer. Mol. Cell. Biol. 8: 62-70.
32. Jeong, S. and A. Stein. 1994. Micrococcal nuclease digestion of nuclei reveals extended nucleosome ladders having anomalous DNA lengths for chromatin assembled on non-replicating plasmids in transfected cells. Nucleic Acids Res. 22: 370-375.
33. Jiang, Y., M. Yan, and J.D. Gralla. 1996. A three-step pathway of transcription initiation leading to promoter clearance at an activation RNA polymerase II promoter. Mol. Cell. Biol. 16: 1614-1621.
34. Johnston, L.A., S.J. Tapscott, and H. Eisen. 1992. Sodium butyrate inhibits myogenesis by interfering with the transcriptional activation function of MyoD and myogenin. Mol Cell. Biol. 12: 5123-5130.
35. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S. Lin, R.A. Heyman, D.W. Rose, C.K. Glass, and M.G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414.
36. Li, H. and Y. Capetanaki. 1994. An E box in the desmin promoter cooperates with the E box and MEF-2 sites of a distal enhancer to direct muscle-specific transcription. EMBO J. 13: 3580-3589.
37. Li, L., J. Zhou, G. James, R. Heller-Harrison, M.P. Czech, and E.N. Olson. 1992. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71: 1181-1194.
38. Loo, S. and J. Rine. 1994. Silencers and domains of generalized repression. Science 264: 1768-1771.
39. Lorico, A., G. Rappa, S. Srimatkandada, C.V. Catapano, D.J. Fernandes, J.F. Germino, and A.C. Sartorelli. 1995. Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene. Cancer Res. 55: 4352-4360.
40. Malik, S., C.F. Huang, and J. Schmidt. 1995. The role of the CANNTG promoter element (E box) and the myocyte-enhancer-bindmg-factor-2 (MEF-2) site in the transcriptional regulation of the chick myogenin gene. Eur. J. Biochem. 230: 88-96.
41. Martin, J.F., L. Li, and E.N. Olson. 1992. Repression of myogenin function by TGF-beta 1 is targeted at the basic helix-loop-helix motif and is independent of E2A products. J. Biol. Chem. 267: 10956-10960.
42. McGhee, J.D., W.I. Wood, M. Engel, and G. Felsenfeld. 1981. A 200 base pair region at the 5′ end of the chicken adult beta-globin gene is accessible to nuclease digestion. Cell 27: 45-55.
43. Molkentin, J.D., B.L. Black, J.F. Martin, and E.N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83: 1125-1136.
44. Morse, R.H. 1993. Nucleosome disruption by transcription factor binding in yeast. Science 262: 1563-1566.
45. Nabcshima, Y., K. Hanaoka, M. Hayasaka, H. Esumi, S. Li, and I. Nonaka. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364: 532-535.
46. Naidu, P.S., D.C. Ludolph, R.Q. To, T.J. Hinterberger, and S.F. Konieczny. 1995. Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis. Mol. Cell. Biol. 15: 2707-2718.
47. Otten, A.D. and S.J. Tapscott. 1995. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc. Natl. Acad. Sci. 92: 5465-5469.
48. Owen-Hughes, T., R.T. Utley, J. Cote, C.L. Peterson, and J.L. Workman. 1996. Persistent site-specific remodeling of a nucleosome array by transient action of the SWI/SNF complex. Science 273: 513-516.
49. Philipsen, S., S. Pruzina, and F. Grosveld. 1993. The minimal requirements for activity in transgenic mice of hypersensitive site 3 of the beta globin locus control region. EMBO J. 12: 1077-1085.
50. Pieper, R., R.L. Slobbe, F.C.S. Ramaekers, H.T. Cuypers, and H. Bloemendal. 1987. Upstream regions of the hamster desmin and vimentin genes regulate expression during in vitro myogenesis. EMBO J. 6: 3611-3618.
51. Reeves, R., C.M. Gorman, and B. Howard. 1985. Minichromosome assembly of non-integrated plasmid DNA tranfected into mammalian cells. Nucleic Acids Res. 13: 3599-3615.
52. Reitman, M. and G. Felsenfeld. 1990. Developmental regulation of topoisomerase II sites and DNase I-hypersensitive sites in the chicken beta-globin locus. Mol Cell. Biol. 10: 2774-2786.
53. Rudnicki, M.A. and R. Jaenisch. 1995. The MyoD family of transcription factors and skeletal myogenesis. BioEssays 17: 203-209.
54. Rudnicki, M.A., P.N. Schnegelsberg, R.H. Stead, T. Braun, H.H. Arnold, and R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75: 1351-1359.
55. Stalder, J., A. Larsen, J.D. Engel, M. Dolan, M. Groudine, and H. Weintraub. 1980. Tissue-specific DNA cleavages in the globin chromatin domain introduced by DNase I. Cell 20: 451-460.
56. Stamatoyannopoulos, J.A., A. Goodwin, T. Joyce, and C.H. Lowrey. 1995. NF-E2 and GATA binding motifs are required for the formation of DNase I hypersensitive site 4 of the human beta-globin locus control region. EMBO J. 14: 106-116.
57. Svaren, J., J. Schmitz, and W. Horz. 1994. The transactivation domain of Pho4 is required for nucleosome disruption at the PHO5 promoter. EMBO J. 13: 4856-4862.
58. Tapscott, S.J., R.L. Davis, M.J. Thayer, F.F. Cheng, H. Weintraub, and A.B. Lassar. 1988. MyoD1: A nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242: 405 -411.
59. Tapscott, S.J., A.B. Lassar, and H. Weintraub. 1992. A novel myoblast enhancer element mediates MyoD transcription. Mol. Cell. Biol. 12: 4994-5003.
60. Thayer, M.J., S.J. Tapscott, R.L. Davis, W.E. Wright, A.B. Lassar, and H. Weintraub. 1989. Positive autoregulation of the myogenic determination gene MyoD1. Cell 58: 241-248.
61. Tsukiyama, T. and C. Wu. 1995. Purification and properties of an ATP-dependent nucleosome remodeling factor. Cell 83: 1011-1020.
62. Tsukiyama, T., C. Daniel, J. Tamkun, and C. Wu. 1995. ISWI, a member of the SWI2/SNF2 ATPase family, encodes the 140 kDA subunit of the nucleosome remodeling factor. Cell 83: 1021-1026.
63. Venter, U., J. Svaren, J. Schmitz, A. Schmid, and W. Horz. 1994. A nucleosome precludes binding of the transcription factor Pho4 in vivo to a critical target site in the PHO5 promoter. EMBO J. 13: 4848-4855.
64. Venuti, J.M., J.H. Morris, J.L. Vivian, E.N. Olson, and W.H. Klein. 1995. Myogenin is required for late but not early aspects of myogenesis during mouse development. J. Cell. Biol. 128: 563-576.
65. Wang, Y., P.N. Sehnegelsberg, I. Dausman, and R. Jaenisch. 1996. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin. Nature 379: 823 -825.
66. Weintraub, H. 1985. Assembly and propagation of repressed and depressed chromosomal states. Cell 42: 705-711.
67. _. 1993. The MyoD family and myogenesis: Redundancy, networks, and thresholds. Cell 75: 1241 -1244.
68. Weintraub, H. and M. Groudine. 1976. Chromosomal subunits in active genes have an altered conformation. Science 193: 848-856.
69. Weintraub, H., S.J. Tapscott, R.L. Davis, M.J. Thayer, M.A. Adam, A.B. Lassar, and A.D. Miller. 1989. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. 86: 5434-5438.
70. Weintraub, H., V.J. Dwarki, I. Verma, R. Davis, S. Hollenberg, L. Snider, A. Lassar, and S.J. Tapscott. 1991. Muscle-specific transcriptional activation by MyoD. Genes & Dev. 5: 1377-1386.
71. Weintraub, H., T. Genetta, and T. Kadesch. 1994. Tissue-specific gene activation by MyoD: Determination of specificity by cis-acting repression elements. Genes &. Dev. 8: 2203-2211.
72. Wolffe, A.P. 1992. New insights into chromatin function in transcriptional control. FASEB J. 6: 3354 -3361.
73. Wong, W., Y. Xue, S. Zhou, A. Kuo, B.R. Cairns, and G.R. Grabtree. 1996. Diversity and specialization of mammalian SWI/SNF complexes. Genes & Dev. 10: 2117-2130.
74. Yee, S.P. and P.W. Rigby. 1993. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes & Dev. 7: 1277-1289.
75. Yuan, W., G. Condorelli, M. Caruso, A. Felsani, and A. Giordano. 1996. Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271: 9009-9013.